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In order to assess the effect of in vitro models on the expression of key genes known to be implicated in the development or
progression of cancer, we quantiﬁed by real-time quantitative PCR the expression of 28 key genes in three bladder cancer
tissue specimens and in their derived cell lines, studied either as one-dimensional single cell suspensions, two-dimensional
monolayers or three-dimensional spheroids. Global analysis of gene expression proﬁles showed that in vitro models had a
dramatic impact upon gene expression. Remarkably, quantitative differences in gene expression of 2–63-fold were observed
in 24 out of 28 genes among the cell models. In addition, we observed that the in vitro model which most closely mimicked in
vivo mRNA phenotype varied with both the gene and the patient. These results provide evidence that mRNA expression
databases based on cancer cell lines, which are studied to provide a rationale for selection of therapy on the basis of
molecular characteristics of a patient’s tumour, must be carefully interpreted.
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Recently, with new genomic technologies, it has become possible to
study the expression patterns of hundred of genes relevant to
tumour development and progression. Gene expression proﬁles
have often been assessed in human cancer cell lines in order to
provide insights into biological events that take place during the
malignant transformation of normal tissues (Kettunen et al,
2001) and to determine pharmacological implications of these
genes in drug sensitivity or chemoresistance (Scherf et al, 2000;
Wang et al, 2001). However, the billions of cells in the human
body are more than a vast biochemical network of gene-encoded
proteins. They are also physical entities with geometric dimensions
and are therefore governed by the laws of macroscopic mechanics
(Huang, 2000). Indeed, an individual normal cell, within the same
biochemical milieu, will divide, differentiate or undergo apoptosis
simply because of its external shape (Huang and Ingber, 1999).
Thus, the aim of this study was to investigate whether in vitro
culture models displaying different cellular architectures inﬂuence
gene expression proﬁles. A schematic view of our overall approach
is shown in Figure 1. Three bladder cancer cell lines established in
our laboratory were used as an experimental model. These cell lines
were studied as either one-dimensional (1-D) single-cell suspen-
sions, two-dimensional (2-D) monolayers or three-dimensional
(3-D) multicellular spheroids comprising 10000 cancer cells. We
focused on the expression of 28 genes well known to be involved
in neoplastic transformation (Hanahan and Weinberg, 2000). These
genes were quantiﬁed by real-time quantitative PCR both in the
cell lines and in the parental bladder cancer tissue specimens
collected from patients.
While pharmacological perspective currently tends to modify the
target approach from a general to an individual treatment strategy,
our data suggested that the in vitro model most precisely mimick-
ing the in vivo situation must be determined for each patient and
for each gene studied. Thus, in addition to expected individual
patient variations, these data highlight the strong discordance
between observations of gene expression in different in vitro
models, providing the context in which current oncogenomic
studies must be interpreted.
MATERIALS AND METHODS
Tissue specimens
Three tumour specimens, Tum 06, Tum 07 and Tum 25, were
obtained from cystectomy of bladder carcinoma patients. After
surgery, a tumour fragment was frozen in liquid nitrogen. Another
fragment was collected in culture medium in order to establish
tumour cell lines using previously reported protocols (Housseau
et al, 1997). Cell lines were of tumour origin as assessed by pheno-
type analysis and karyology (Dr B Dutrillaux, Institut Curie, Paris,
France). Moreover, the origin of tumour cell lines was certiﬁed by
HLA typing (Dr G Semana, Etablissement Re ￿gional de Transfusion
Sanguine de Bretagne-Est, Rennes, France). Histology and percen-
tage of viable tumour cells in each specimen were determined by
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www.bjcancer.comvisual examination of adjacent sections stained with haematoxylin
and eosin. Tum 06 was an adenocarcinoma and both Tum 07
and Tum 25 were transitional cell carcinomas. Tissue specimens
from tumours Tum 07, Tum 25 and Tum 06 contained 80, 50
and 40% of tumour cells, respectively.
In vitro cell culture
All types of cultures were cultured in the same medium consisting
of RPMI 1640 with 4610
75 M 2-b-mercaptoethanol, 2 mML -
glutamine, penicillin (100 U ml
71), streptomycin (100 mgm l
71),
1% sodium pyruvate, 0.1 mM non-essential amino acids, referred
to as culture medium, supplemented with 10% heat-inactivated
FCS and 10 mgm l
71 insulin (Sigma, Saint-Louis, MO, USA).
Monolayers, suspensions and spheroids were obtained using the
same thawed cell sample corresponding to the 26th, the 12th and
the 11th passage of Tum 06, Tum 07 and Tum 25, respectively.
Monolayer cultures were grown by seeding 0.5610
6 cells per
75 cm
2 tissue culture ﬂask. RNA extraction was performed on
subconﬂuent cultures. Cell suspensions generated by trypsinization
of tumour monolayers were resuspended in 10 ml of culture
medium in a centrifuge tube for 1 h at 378C in a humidiﬁed 5%
CO2 incubator before RNA preparation. Multicellular spheroids
were prepared in 96-well V-bottom culture dishes coated with
poly-(2 hydroxyethyl metacrylate) (Sigma) as previously described
(Dangles et al, 1997). After 5 days, spheroids contained an average
number of 10000 cells and were collected for RNA extraction.
Trypan blue experiments performed on suspensions, monolayers
or spheroids showed that cell culture conditions did not alter cell
viability.
Determination of mRNA levels using real-time PCR
Total RNA was isolated from either tissue samples or cultured cells
by the acid-phenol guanidinium method, using RNAble (Bioprobe
France). Total RNA concentration was determined at 260 nm and
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• MYC (c-myc)
• FAS (Fas)
• FASL (Fas-L)
• TP53 (p53)
• BCL2 (bcl2)
• CASP9 (Caspase 9)
• IGF1 (IGF1a)
• IGF2 (IGF2)
• CGB (hCGb)
Evading
apoptosis
• HTRT (telomerase)
• IGF1 (Ki-ras)
• CDKN2A (p16)
• CDK4 (CDK4)
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• TGFA (TGFa)
• EGFR (EGF-R)
• KRAS2 (Ki-ras)
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in growth
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• MYC (c-myc)
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• CDK4 (CDK4)
• CYCD1 (cyclin D1)
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Figure 1 Design of the study. Expression proﬁles of genes involved in six essential alterations in cell physiology that collectively dictate malignant growth
were studied in tissue specimens collected from three bladder tumours and in vitro cell culture models derived from these tumours and displaying three
different architectural structures: one-dimensional (1-D) single cell suspensions, two-dimensional (2-D) monolayer cells or three-dimensional (3-D) multi-
cellular spheroids. (A) Tumour specimen Tum 25, taken as representative. (B) Tum 25 cell suspension. (C) Tum 25 monolayer. (D) Tum 25 spheroid
containing 10000 tumour cells.
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of total RNA from each sample was reverse-transcribed and real-
time quantitative PCR was conducted on an ABI prism SDS
7700 system (Perkin-Elmer Applied Biosystems Inc., Foster City,
CA, USA), as previously described (Lazar et al, 1999). Brieﬂy,
oligonucleotide primers and TaqMan probes for analysed genes
were designed for intron spanning using the computer program
Primer Express (Perkin-Elmer Applied Biosystems Inc.) and
sequences from the NCBI gene bank. Real-time quantitative PCR
was achieved using a cDNA equivalent of 20 ng total RNA/50 ml
per tube with the TaqMan
1 PCR Universal Master mix: 16
master mix (containing 5 mM MgCl2, 200 mM dA/C/G, 400 mM
dU, 1.25 U AmpliTaq Gold
1 DNA polymerase, 2.5 U uracil N-
glycosylase and glycerol), 100 mM TaqMan probe and 200 mM of
each primer. To normalise for differences in the amount of total
RNA added to the reaction, ampliﬁcation of 18S ribosomal RNA
was performed as an endogenous control. Primers and probes for
18S RNA were purchased from Perkin Elmer Applied Biosystems
Inc.
To quantify the gene expression proﬁle in each specimen we
used the comparative threshold cycle (Ct) method according to
the manufacturer’s instructions. For each in vitro cellular model,
a calibrator was constituted by the corresponding tumour specimen
RNA. It was used as the 16sample (or 100%) and all other levels
(cultured cells) were expressed as an n-fold difference relative to
this calibrator. The intra-assay coefﬁcient of variations was less
than 1%.
Statistical analysis
Comparisons used general linear ANOVA models with the multiple
comparison Bonferroni test. There were six measurements (six
different total RNAs generated from six independent cultures)
per gene (28 genes), per culture condition (three differing in vitro
cell models) and per tumour tissue (three tumour specimens),
leading to 1512 measurements. mRNA levels measured by real time
quantitative PCR were transformed in logs to normalise distribu-
tion. To assess whether given gene expression for a given
architecture and a given tumour was signiﬁcantly different from
in vivo measurement, the mean value of the six measurements
was compared to one by the t-test, as all genes had been expressed
as n-fold the calibrator. NCSS statistical software was used (Hintze
JL. NCSS 97 User Guide. Number Cruncher Statistical Systems.
Kaysville, UT, USA). To investigate which of the three in vitro cell
models led to the gene proﬁle closest to that observed in vivo for a
speciﬁc gene and a speciﬁc tumour, the three values were
compared by variance analysis and the multiple Bonferroni t-test
if variance analysis was signiﬁcant.
RESULTS
In vitro cell culture model and gene expression
Transitional cell bladder carcinoma fragments were obtained from
patients after surgery (Figure 1A). We had previously established
the two bladder carcinoma cell lines Tum 06 and Tum 07 from
such tissue specimens (Housseau et al, 1997) and the additional
autologous cell line Tum 25 was obtained with the same protocol.
These three cell lines were studied in vitro as either (1-D) single cell
suspensions (Figure 1B), (2-D) monolayer cells (Figure 1C), or (3-
D) multicellular spheroids containing 10000 cells (Figure 1D). In
vitro cell architecture of spheroids was compared to that of tumour
cells present in vivo within the tissue specimen. Histological
features, including tight compaction, numerous mitoses and
nucleolar atypia had led to the conclusion that the urothelial carci-
noma cell microtumours obtained in vitro with spheroids were
comparable to those observed upon cytological analysis of carcino-
ma abdominal spread.
The expression proﬁles of 28 genes known to be involved in
malignant growth were studied in three bladder carcinoma frag-
ments representative of the tumours in their in vivo architecture
and in derived bladder cancer cells displaying different in vitro
models. These genes were selected for their role in six essential
alterations in cell physiology that collectively dictate malignant
growth (Gilles et al, 1996; Bellet et al, 1997; Hendrix et al, 1997;
Vlodavsky et al, 1999; Butler et al, 2000; Hanahan and Weinberg,
2000) (Figure 1). Real-time kinetic quantitative PCR was used to
determine mRNA levels. To validate the real-time PCR method,
standard curves for a given gene and for 18S ribosomal RNA were
constructed from PCR products. 18S ribosomal RNA was used as
standard, after comparison with TBP or PPIA, and was found to
provide gene expression patterns similar to those provided with
these transcripts as control genes (data not shown). Figure 2 shows
the ampliﬁcation plots (Figure 2A–C) and the expression levels
(Figure 2D–F) of MYC, CGB and ECAD mRNAs, taken as repre-
sentative, in Tum 06, Tum 07 and Tum 25 tissues and their
associated cell lines.
Global mathematical analysis of the expression proﬁle of the 28
key genes shows that the in vitro cell model has a striking effect
upon gene expression: statistically signiﬁcant differences between
mRNA levels were consistently observed depending upon the 1-
D, 2-D, or 3-D in vitro model of cell lines whatever the parental
tumour. Indeed, there was a signiﬁcant culture condition effect
(F-Ratio=29; Degree Freedom=2; P50.001). Interestingly, indepen-
dent transcript analysis for each gene showed that this effect varied
widely. Thus, a change in 1-D to 3-D cellular structure could, for
example, lead to increased or reduced mRNA levels (Figure 2D–
F). In addition to the inﬂuence of the in vitro model on gene
expression, there was a signiﬁcant tumour effect (F-Ratio=42;
Degree Freedom=2; P50.001) and a signiﬁcant gene effect (F-
ratio=171; Degree Freedom=27; P50.001). For a given gene, varia-
tions in culture conditions could lead to either an increase or a
decrease in mRNA levels, depending upon the tumour (Figure
3A). Collectively, quantitative differences of between two-fold
and 63-fold were observed for 24 out of 28 genes depending upon
the tumour and the in vitro model: the 12 genes most up- or
down-regulated by modiﬁed tumour culture are presented in
Table 1.
In vitro culture model and in vivo gene expression
In addition to this systematic study of the effects of in vitro culture
conditions on gene expression, we were interested in determining
whether a given in vitro tumour model closely mimics the in vivo
gene expression proﬁles observed in cancer tissue. To conduct this
investigation, we compared the expression proﬁles observed in the
differing in vitro models with in vivo gene expression phenotypes.
When all in vitro models displayed a signiﬁcant difference in gene
expression from the tumour specimen, we determined, when poss-
ible, the model which was closest to the in vivo situation. It is
apparent that an in vitro cellular model displaying a gene expres-
sion proﬁle similar to that observed in vivo varies with both the
gene and the tumour (Figure 3B). As a representative example,
we observed that a 3-D in vitro model leads to an in vitro gene
proﬁle similar to that displayed in vivo for TP53 or CDKN2B only
in Tum 06, for FasL only in Tum 07 or for KRT8 only in Tum 25.
DISCUSSION
Advances in molecular technology promise to yield quantitative
measurements of thousands of mRNA levels at once, paving the
way for such applications as molecular tumour proﬁling and
precise tailoring of individual chemotherapy regimens. Most of
these mRNA expression databases were obtained with cancer cell
lines, particularly from the NCI-ACDS panel (Amundson et al,
2000; Scherf et al, 2000), to determine genes involved in drug
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(8), 1283–1289sensitivity or cancer progression (Kettunen et al, 2001; Wang et al,
2001). Moreover, it is noteworthy that in vitro experiments tradi-
tionally use a 1-D or 2-D tumour cell model, whereas solid
cancer cells display a 3-D geometry in vivo. Despite the fact that
these basic parameters were not frequently taken into account, they
have been demonstrated to have dramatic impact on biological
responses of cells to differing stimuli (Mansbridge et al, 1994;
Dangles et al, 1997; Huang and Ingber, 1999; Lang et al, 2001).
In this context, the present study was designed to determine the
inﬂuence of in vitro cell models on gene expression proﬁles. With
this aim, we took advantage of three bladder cancer cell lines estab-
lished in our laboratory from parental tissue specimens and
cultured in 1-D, 2-D or 3-D. We then studied genes implicated
in six key alterations governing oncogenesis: self-sufﬁciency in
growth signals, insensitivity to growth-inhibitory (antigrowth)
signals, evasion of apoptosis, limitless replicative potential,
sustained angiogenesis, and tissue invasion and metastasis.
In a ﬁrst step, our ﬁndings demonstrated solid data of evidence
for an impact of an in vitro model on gene expression. For 12 out
of 28 studied genes, comparison of the transcript levels depending
upon the in vitro culture condition showed rising ratio values from
ﬁve to 63. It is noteworthy that 24 genes out of 28 presented varia-
tions superior to two, while, in a study based on conventional
monolayers, only 28 of 1176 genes were altered 41.5-fold in ﬁve
chemoresistant cell lines compared with the sensitive parental cell
lines (Wang et al, 2001). Likewise, four out of 28 genes (14.2%)
with an intensity ratio 43 were up- or down-regulated in the three
bladder cancer cell lines in our study, whereas only 39 genes out of
588 (6.6%) were so modiﬁed in three malignant mesothelioma cell
lines compared with a reference non tumoural cell line (Kettunen
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Figure 2 Impact of tumour architecture on gene expression. mRNA levels in tumour tissue specimens and in tumoral cell lines displaying 1-D, 2-D or 3-D
structures were determined by real-time quantitative PCR. (A–C) Ampliﬁcation plots; (D–F) expression levels in tissue (pink), in 1-D cell suspensions
(blue), in 2-D monolayers (green), and in 3-D spheroids (orange), using each tumour specimen as the calibrator for the respective cell lines. Levels are
expressed as an n-fold difference relative to the calibrator. All data are expressed as the mean+s.e.m. of at least two separate experiments carried out
in triplicate. *, P50.001, compared with other in vitro cell models (Bonferroni Multiple Comparison Test). (A, D) MYC gene encoding c-myc in tumour
or cell line Tum 06. (B, E) CGB genes encoding hCGb in tumour or cell line Tum 07. (C, F) ECAD gene encoding E-cadherin in tumour or cell line
Tum 25, taken as representative.
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British Journal of Cancer (2002) 86(8), 1283–1289 ã 2002 Cancer Research UKet al, 2001). Moreover, four genes had expression levels varying
between 1.5- and two-fold but it is unclear whether these lower
gene expression differences reﬂected true variations due to culture
changes or gene-speciﬁc noises due to uncharacterized perturba-
tions (Hughes et al, 2000). Interestingly, average values obtained
for these ratios can be aligned with previous data obtained in vivo
in normal and cancer cells of differing histological types by SAGE,
array technologies or quantitative PCR (Zhang et al, 1997; Lal et al,
1999; Nacht et al, 1999; Sgroi et al, 1999). Collectively, it was
shown that: (i) the vast majority of genes do not display differen-
tial expression; (ii) a limited subset of genes is differentially
expressed at between 5- and 100-fold; and (iii) very few genes
display gene expression differences higher than 100-fold between
normal and cancer cells. With these data in mind, it is striking that
changes in in vitro cellular models have a dramatic effect upon
expression of key genes involved in malignant transformation, lead-
ing to differences attaining 63-fold. There are several possible
explanations for the dramatic impact of in vitro cellular models.
First, cell–cell interactions markedly differ between these three in
vitro models, leading to changes in cellular geometry which could
modify gene expression through mechanical forces or cell distor-
tion (Huang and Ingber, 1999; Huang, 2000). Furthermore,
variations in cell growth rates under the different culture condi-
tions (data not shown) may participate in this phenomenon.
Cell-to-cell contact might in any case either directly regulate gene
expression, particularly the expression of genes involved in prolif-
eration and apoptosis, or indirectly interact with gene expression
through cell growth and viability functions.
We then studied whether an in vitro culture model, 1-D, 2-D or
3-D, might mimic the in vivo gene expression phenotypes. Our
ﬁndings showed that in vitro culture conditions which display
the gene proﬁles resembling those observed in vivo vary with both
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Figure 3 (A) Relative expression level of a given gene in a given tissue (mean value of six measurements) and expressed as n-fold the calibrator (tumour
specimen RNA used as the 16sample):(x), no detectable transcripts. (B) Comparison of mRNA levels displayed by in vitro cell cultures with mRNA levels
observed in vivo: black, no detectable transcripts; green, no statistical difference in mRNA levels between in vitro and in vivo cells; red, statistical difference in
mRNA levels between in vitro and in vivo cells; orange, in vitro structure displaying mRNA levels which were closest to in vivo mRNA levels among the three
signiﬁcantly different models (P50.03, Bonferroni Multiple Comparison Test).
Table 1 Genes most strongly induced or reduced by changes in cell cul-
ture conditions
Architecture
Gene Product Tumour change
a Fold change
b
CGB hCGb Tum 07 3-D vs 2-D Decrease 636
BCL2 bcl2 Tum 07 3-D vs 2-D Decrease 216
CDKN2B p15 Tum 25 3-D vs 2-D Increase 136
PLAUR UPA-R Tum 25 3-D vs 2-D Increase 126
MYC c-myc Tum 06 3-D vs 1-D Decrease 126
HTRT Telomerase Tum 06 3-D vs 1-D Decrease 106
KRT8 Cytokeratin 8 Tum 07 3-D vs 1-D Decrease 76
CYCD1 Cyclin D1 Tum 06 3-D vs 1-D Decrease 76
ECAD E-Cadherin Tum 25 3-D vs 1-D Increase 66
KRAS2 Ki-ras Tum 25 3-D vs 2-D Increase 66
CDKN2A p16 Tum 06 3-D vs 1-D Decrease 66
VEGF VEGF Tum 07 2-D vs 1-D Decrease 56
aChange in a given cell model (1-D suspension cells, 2-D monolayers or 3-D spher-
oids) in comparison to another cell model.
bThe n-fold increase or decrease in gene
expression was calculated by taking the ratio of means of expression levels. These
ratios were signiﬁcant with a P value 50.05 (Bonferroni test).
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(8), 1283–1289the gene and the patient. Indeed, 3-D was expected to be the most
appropriate model for mimicking in vivo mRNA levels: parafﬁn
sections of spheroids clearly showed that spheroid histoarchitecture
was similar to in vivo tumour aggregates of disseminated carcino-
ma in ascites ﬂuid, thereby suggesting the interest of spheroids as
an in vivo-like model (Kunz-Schughart et al, 1998; Santini and
Rainaldi, 1999). Interestingly, our results demonstrate that the 3-
D spheroid is the most appropriate model for a limited subset of
genes in a given tumour. However, it is highly likely that the
heterogeneity of the tumour specimen has to be taken into account
for a more thorough interpretation of these data. In this regard, it
is noteworthy that the number of genes displaying an in vitro
expression resembling that observed in vivo is higher for Tum 07
which contains the highest percentage of neoplastic cells (80%),
in comparison to Tum 25 and Tum 06 (50 and 40%, respectively).
As a representative example, no statistical difference in mRNA
levels between in vitro cells in 1-D and in vivo cells was observed
for 15 out 28 genes for Tum 07 in comparison to 11 and 10 out
of 28 for Tum 06 and Tum 25, respectively. These results must
be put in line with a recent analysis of mRNA proﬁles in prostate
cancer which revealed a major division between cells grown in vitro
and human tissue specimens, with highly divergent gene expression
patterns (Welsh et al, 2001). The authors hypothesised that,
because of the small number of genes with concordant expression
in cell lines and malignant tissues, cell lines had lost many features
that characterise prostate cancer in vivo. Nevertheless, the present
data indicate that it is necessary to select, for a given gene and a
given tumour, the in vitro model most closely mimicking in vivo
expression of this gene. Moreover, in light of numerous reports
underlining the disparity between mRNA transcript and protein
levels (Simpson and Dorow, 2001), such mRNA expression studies
should be supported by proteomic information to provide a
complete picture of the in vitro model most closely mimicking
the in vivo phenotype of the tumours.
Finally, these observations highlight complex regulation of the
30000 human genes (Claverie, 2001) through the example of the
dramatic inﬂuence of culture conditions on the expression of genes
involved in malignant growth. Because we analysed a limited
number of specimens, additional experiments using high through-
put techniques are required to determine how commonly these
genes are differentially expressed. Indeed, gene expression proﬁling
using hundreds of genes might be useful not only for further char-
acterising one of the three in vitro models of the tumour-derived
cell lines, singling out their use as the most advantageous tumour
model, but also for identifying genes associated with the phenotype
of bladder cancers. However, our ﬁndings have important implica-
tions for the interpretation of data in the postgenome era, at the
very time when gene expression is a prerequisite for designing
and choosing an individual basis for speciﬁc therapies suited to
individual patients.
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